#ESMO24: Do not miss the latest #CancerResearch brought to you by the #ESMOAmbassadors & become part of the conversation. 📌 ow.ly/PgWM50Th6Q3

Introducing our Survivorship Study Group, whose recent projects include MASCC-ASCO standards and practice recommendations on survivorship care for people affected by advanced or metastatic cancer: (available in 14 languages!): mascc.org/resources/masc…

New recommendation for annual pancreatic cancer screening for people >50 years old with pathogenic ATM and BRCA mutations. #bcsm #gyncsm #survivorship #BRCA #ATM

Our Supportive Care 2030 Movement Ambition Statements are now published in the The Lancet's eClinicalMedicine – The Lancet Discovery Science. MASCC as the pre-eminent leader in #supponc will work with our partners around the globe to achieve these share ambitions. Full Article tinyurl.com/2b3ksu9e

Can you spot Julia Maués and Christine Hodgdon participating in a BIG way at the BIG against Breast Cancer BIG-PPI? #advocayinaction #partnership #commitment

Happy to join #ESMO24 Looking forward to conversations and collaborations

More info below Journal of Cancer Survivorship #ayacsm #Survonc ⤵️

Dear #ESMO24 We Are HERE WE ARE OncoAlert 🚨 Matteo Lambertini, MD PhD Philippe Aftimos, MD  Evandro de Azambuja, MD, PhD Nicole Kuderer, MD, MS, FASCO 🌎🇺🇸🇪🇺🇺🇦🌏 FabriceAndre Aleix Prat #PrecisionOncology Stephanie Graff, MD, FACP, FASCO 𝙅𝙚𝙨𝙪𝙨 𝘼𝙣𝙖𝙢𝙥𝙖 𝙈.𝘿, 𝙈.𝙎🧬🔬 Daniel Stover, MD, FASCO G Curigliano MD PhD Erika Hamilton, MD Double Whammy Dr. Kelly Shanahan Stacey Tinianov (she/her) MPH, BCPA Julia Maués Maryam Lustberg MD, MPH, FASCO IBC Research Fdn Kevin Punie

First results from DESTINY-Breast12 of T-DXd for patients with HER2+ MBC with or without brain metastases: 🔹 Median PFS = 17.3 months in patients with brain metastases 🔹CNS objective response rate = 71.7% #bcsm #ESMO24 #ESMOAmbassadors ESMO - Eur. Oncology

If only patients with unstable brain mets had been allowed on the original trial back in 2019… Despite all the clinical trial eligibility criteria work by Nancy Lin, MD and others, it took a whole 5 years to get here! #ESMO24

GRASP is attending ESMO this week in person, so if you happen to be in Barcelona and see us, say hello! ESMO’s core mission is to improve the quality of cancer care, from prevention and diagnosis to palliative care and patient follow-up. #ESMO #GRASPinaction

Grateful to YaleBreastCancer Yale Surgery and the incredible interdisciplinary team Smilow Cancer Hospital Waterford/ LMH for welcoming me to the team. I'm so fortunate to now provide breast surgical oncology care to pts in my community living on the CT/RI Shoreline in addition to New Haven!

Terrific ending for #ESMO24 day one, getting to connect, chat, hug, celebrate with some of the kindest and strongest voices in oncology— thank you OncoDaily for one more superb party! Maryam Lustberg MD, MPH, FASCO Philippe Aftimos, MD  Julia Maués Christine Hodgdon

Early tomorrow morning, Drs. Barbara Burtness, Austin Mattox, Maryam Lustberg MD, MPH, FASCO, and Hermine Poghosyan Yale Nursing will be sharing presentations at #ESMO2024. Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp

Destiny-Breast12: One of the highlights at #ESMO24 presented by Nancy Lin, MD. Practice changing data for #mBC patients with HER+ disease and brain metastases. So finally patients with active brain metastases are being included in trials. OncoAlert

Call for Papers for a section on "The lived experiences of AYA cancer survivors: Narratives and evidence." We seek brief firsthand accounts from AYA survivors. Submit a 1-page cover letter confirming you fit criteria & outlining your focused topic! #AYACsm #Survivorship #SurvOnc

The #ESMOYOC boxing session has just started in hall 7 Cartagena room!!! Super faculty with Myriam Chalabi Jon Lim, MRCP PhD Liz Connolly Emre Kocakavuk, MD, PhD Maryam Lustberg MD, MPH, FASCO Alice Indini 🔥🤩🔝 #ESMO24 #ESMOAmbassadors ESMO - Eur. Oncology OncoAlert

#supponc

#ESMO2024 highlight! Maryam Lustberg MD, MPH, FASCO GRASP